| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Abruptio Placentae | 28 | 2021 | 118 | 10.050 |
Why?
|
| Pregnancy Complications | 77 | 2022 | 2942 | 8.940 |
Why?
|
| Diabetes, Gestational | 52 | 2023 | 1241 | 6.840 |
Why?
|
| Pregnant Women | 28 | 2022 | 562 | 6.050 |
Why?
|
| Pre-Eclampsia | 59 | 2023 | 1227 | 5.980 |
Why?
|
| Pregnancy | 266 | 2023 | 29742 | 5.230 |
Why?
|
| Peru | 63 | 2022 | 884 | 5.160 |
Why?
|
| Spouse Abuse | 14 | 2018 | 182 | 3.960 |
Why?
|
| Suicidal Ideation | 19 | 2022 | 1430 | 3.840 |
Why?
|
| Migraine Disorders | 30 | 2021 | 1694 | 3.520 |
Why?
|
| Birth Weight | 25 | 2019 | 2097 | 2.810 |
Why?
|
| Adult Survivors of Child Abuse | 9 | 2019 | 285 | 2.780 |
Why?
|
| Premature Birth | 23 | 2021 | 1771 | 2.660 |
Why?
|
| Washington | 39 | 2018 | 312 | 2.550 |
Why?
|
| Stress, Psychological | 20 | 2019 | 4455 | 2.440 |
Why?
|
| Depression | 33 | 2022 | 8057 | 2.400 |
Why?
|
| Students | 15 | 2020 | 1734 | 2.190 |
Why?
|
| Body Mass Index | 60 | 2024 | 12876 | 2.140 |
Why?
|
| Hair | 6 | 2023 | 497 | 2.100 |
Why?
|
| Adult | 294 | 2024 | 219935 | 2.090 |
Why?
|
| Placenta | 15 | 2023 | 1702 | 1.980 |
Why?
|
| Hydrocortisone | 8 | 2023 | 1802 | 1.980 |
Why?
|
| Gestational Age | 30 | 2019 | 3565 | 1.910 |
Why?
|
| Female | 365 | 2024 | 390323 | 1.880 |
Why?
|
| Odds Ratio | 58 | 2019 | 9650 | 1.870 |
Why?
|
| Young Adult | 125 | 2024 | 58808 | 1.830 |
Why?
|
| Depression, Postpartum | 7 | 2019 | 345 | 1.760 |
Why?
|
| Pregnancy Trimester, First | 18 | 2021 | 908 | 1.740 |
Why?
|
| DNA, Mitochondrial | 5 | 2017 | 856 | 1.710 |
Why?
|
| Pregnancy Outcome | 28 | 2019 | 2907 | 1.690 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 9 | 2016 | 1079 | 1.690 |
Why?
|
| Depressive Disorder | 13 | 2018 | 3727 | 1.670 |
Why?
|
| Sleep | 16 | 2022 | 4744 | 1.660 |
Why?
|
| Battered Women | 7 | 2015 | 36 | 1.660 |
Why?
|
| Disabled Children | 4 | 2015 | 251 | 1.630 |
Why?
|
| Cross-Sectional Studies | 82 | 2024 | 25956 | 1.620 |
Why?
|
| Risk Factors | 152 | 2022 | 73809 | 1.620 |
Why?
|
| Physical Exertion | 4 | 2019 | 662 | 1.620 |
Why?
|
| Snoring | 4 | 2017 | 206 | 1.520 |
Why?
|
| Child Abuse | 6 | 2017 | 1068 | 1.480 |
Why?
|
| Prevalence | 58 | 2021 | 15651 | 1.460 |
Why?
|
| Ethiopia | 22 | 2018 | 462 | 1.460 |
Why?
|
| Obesity | 41 | 2024 | 12870 | 1.420 |
Why?
|
| Maternal Age | 22 | 2017 | 807 | 1.390 |
Why?
|
| Anxiety Disorders | 11 | 2022 | 2714 | 1.380 |
Why?
|
| Humans | 391 | 2024 | 758406 | 1.380 |
Why?
|
| Obstetric Labor, Premature | 7 | 2014 | 274 | 1.340 |
Why?
|
| Child Abuse, Sexual | 4 | 2015 | 394 | 1.300 |
Why?
|
| Stillbirth | 5 | 2019 | 368 | 1.300 |
Why?
|
| Logistic Models | 51 | 2022 | 13276 | 1.290 |
Why?
|
| Thailand | 15 | 2015 | 288 | 1.270 |
Why?
|
| Case-Control Studies | 69 | 2019 | 22029 | 1.270 |
Why?
|
| Socioeconomic Factors | 39 | 2021 | 7818 | 1.240 |
Why?
|
| Stress Disorders, Post-Traumatic | 12 | 2024 | 4560 | 1.230 |
Why?
|
| Brain-Derived Neurotrophic Factor | 3 | 2017 | 597 | 1.210 |
Why?
|
| Cadmium | 4 | 2018 | 215 | 1.180 |
Why?
|
| Overweight | 18 | 2019 | 2411 | 1.170 |
Why?
|
| Suicide, Attempted | 5 | 2019 | 1383 | 1.150 |
Why?
|
| Hypertension | 16 | 2023 | 8499 | 1.110 |
Why?
|
| Menarche | 4 | 2024 | 529 | 1.100 |
Why?
|
| Fetal Membranes, Premature Rupture | 7 | 2018 | 137 | 1.100 |
Why?
|
| Adolescent | 83 | 2024 | 87892 | 1.060 |
Why?
|
| Obstetric Labor Complications | 2 | 2019 | 236 | 1.050 |
Why?
|
| Glucose Intolerance | 5 | 2017 | 575 | 1.040 |
Why?
|
| Weight Gain | 12 | 2016 | 2346 | 1.020 |
Why?
|
| Placentation | 4 | 2023 | 78 | 1.020 |
Why?
|
| Blood Pressure | 17 | 2019 | 8451 | 1.010 |
Why?
|
| Prenatal Care | 11 | 2017 | 1129 | 0.970 |
Why?
|
| Fetal Growth Retardation | 6 | 2023 | 579 | 0.970 |
Why?
|
| Pregnancy Trimester, Second | 11 | 2019 | 732 | 0.960 |
Why?
|
| Cohort Studies | 63 | 2024 | 41256 | 0.960 |
Why?
|
| Fatty Acids, Omega-6 | 6 | 2016 | 226 | 0.950 |
Why?
|
| Mothers | 11 | 2021 | 2189 | 0.950 |
Why?
|
| Fetal Development | 7 | 2016 | 766 | 0.930 |
Why?
|
| Prospective Studies | 81 | 2021 | 54137 | 0.930 |
Why?
|
| Maternal Exposure | 6 | 2018 | 1045 | 0.910 |
Why?
|
| Anger | 4 | 2019 | 401 | 0.910 |
Why?
|
| Pregnancy Trimesters | 5 | 2015 | 197 | 0.890 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 7 | 2016 | 388 | 0.880 |
Why?
|
| Perinatal Care | 4 | 2018 | 242 | 0.880 |
Why?
|
| Universities | 7 | 2020 | 993 | 0.860 |
Why?
|
| Infant Mortality | 3 | 2019 | 757 | 0.850 |
Why?
|
| Health Behavior | 7 | 2019 | 2617 | 0.830 |
Why?
|
| Glucose Tolerance Test | 8 | 2018 | 1172 | 0.820 |
Why?
|
| Confidence Intervals | 16 | 2015 | 2925 | 0.800 |
Why?
|
| Health Surveys | 10 | 2019 | 4064 | 0.800 |
Why?
|
| Psychometrics | 11 | 2022 | 3052 | 0.790 |
Why?
|
| Social Support | 5 | 2020 | 2155 | 0.790 |
Why?
|
| Circadian Rhythm | 6 | 2022 | 2567 | 0.780 |
Why?
|
| Pregnancy Complications, Cardiovascular | 4 | 2017 | 515 | 0.780 |
Why?
|
| Violence | 3 | 2017 | 934 | 0.780 |
Why?
|
| Sex Offenses | 3 | 2017 | 355 | 0.770 |
Why?
|
| Anxiety | 7 | 2022 | 4539 | 0.760 |
Why?
|
| Gene Dosage | 3 | 2015 | 1218 | 0.750 |
Why?
|
| C-Reactive Protein | 7 | 2017 | 3812 | 0.750 |
Why?
|
| Women's Health | 7 | 2022 | 2057 | 0.740 |
Why?
|
| Genomic Imprinting | 2 | 2020 | 330 | 0.740 |
Why?
|
| Body Weight | 12 | 2019 | 4603 | 0.730 |
Why?
|
| Uterine Hemorrhage | 2 | 2016 | 242 | 0.730 |
Why?
|
| Sleep Deprivation | 5 | 2015 | 840 | 0.720 |
Why?
|
| Vitamin D | 9 | 2016 | 3283 | 0.720 |
Why?
|
| Menstrual Cycle | 4 | 2024 | 536 | 0.710 |
Why?
|
| Smoking | 19 | 2017 | 9051 | 0.710 |
Why?
|
| Hypertension, Pregnancy-Induced | 4 | 2015 | 517 | 0.710 |
Why?
|
| Life Style | 13 | 2017 | 3886 | 0.710 |
Why?
|
| Gonadal Steroid Hormones | 2 | 2014 | 701 | 0.690 |
Why?
|
| Occupations | 4 | 2013 | 515 | 0.680 |
Why?
|
| Caregivers | 4 | 2015 | 2225 | 0.680 |
Why?
|
| Blood Pressure Determination | 4 | 2015 | 634 | 0.680 |
Why?
|
| Chile | 7 | 2022 | 255 | 0.680 |
Why?
|
| Developing Countries | 5 | 2016 | 2866 | 0.670 |
Why?
|
| Natural Language Processing | 2 | 2018 | 1134 | 0.670 |
Why?
|
| Ecosystem | 1 | 2024 | 487 | 0.670 |
Why?
|
| Caffeine | 3 | 2013 | 701 | 0.660 |
Why?
|
| Mass Screening | 8 | 2018 | 5427 | 0.660 |
Why?
|
| Vitamin D Deficiency | 5 | 2015 | 1377 | 0.650 |
Why?
|
| Domestic Violence | 3 | 2010 | 181 | 0.650 |
Why?
|
| Motor Activity | 9 | 2017 | 2685 | 0.640 |
Why?
|
| Pregnancy Trimester, Third | 2 | 2018 | 582 | 0.640 |
Why?
|
| Depressive Disorder, Major | 7 | 2016 | 4745 | 0.640 |
Why?
|
| Cross-Cultural Comparison | 5 | 2015 | 635 | 0.630 |
Why?
|
| Health Knowledge, Attitudes, Practice | 6 | 2015 | 3992 | 0.630 |
Why?
|
| Life Change Events | 3 | 2015 | 953 | 0.630 |
Why?
|
| Infant, Newborn | 35 | 2021 | 26183 | 0.630 |
Why?
|
| Waist Circumference | 5 | 2019 | 921 | 0.620 |
Why?
|
| Mental Disorders | 7 | 2022 | 6803 | 0.620 |
Why?
|
| Oscillometry | 2 | 2015 | 145 | 0.610 |
Why?
|
| Sleep Apnea Syndromes | 4 | 2015 | 973 | 0.610 |
Why?
|
| Mood Disorders | 4 | 2012 | 1124 | 0.600 |
Why?
|
| Infant, Low Birth Weight | 8 | 2019 | 859 | 0.600 |
Why?
|
| Reproducibility of Results | 22 | 2022 | 20055 | 0.590 |
Why?
|
| Comorbidity | 17 | 2017 | 10495 | 0.590 |
Why?
|
| Prenatal Diagnosis | 4 | 2014 | 1264 | 0.590 |
Why?
|
| Lipids | 10 | 2017 | 3326 | 0.580 |
Why?
|
| Beverages | 2 | 2013 | 819 | 0.570 |
Why?
|
| Saliva | 4 | 2019 | 820 | 0.570 |
Why?
|
| Fetal Blood | 2 | 2014 | 1343 | 0.570 |
Why?
|
| Blood Glucose | 12 | 2023 | 6346 | 0.560 |
Why?
|
| Maternal Welfare | 5 | 2014 | 112 | 0.550 |
Why?
|
| Leisure Activities | 6 | 2018 | 306 | 0.550 |
Why?
|
| Labor, Induced | 1 | 2018 | 151 | 0.550 |
Why?
|
| Parturition | 2 | 2018 | 446 | 0.550 |
Why?
|
| Family Conflict | 2 | 2015 | 94 | 0.550 |
Why?
|
| Insulin Resistance | 4 | 2023 | 3941 | 0.550 |
Why?
|
| Male | 113 | 2023 | 358747 | 0.540 |
Why?
|
| Dyslipidemias | 3 | 2017 | 867 | 0.540 |
Why?
|
| Asthma | 6 | 2017 | 6172 | 0.540 |
Why?
|
| Diet | 9 | 2018 | 8005 | 0.540 |
Why?
|
| Leptin | 6 | 2015 | 1591 | 0.540 |
Why?
|
| Health Status | 5 | 2019 | 4071 | 0.530 |
Why?
|
| Fatty Acids, Omega-3 | 8 | 2016 | 1373 | 0.530 |
Why?
|
| Child of Impaired Parents | 1 | 2019 | 459 | 0.520 |
Why?
|
| Extraembryonic Membranes | 1 | 2015 | 38 | 0.520 |
Why?
|
| Cryptochromes | 1 | 2015 | 48 | 0.520 |
Why?
|
| Physical Examination | 5 | 2014 | 1245 | 0.510 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 1 | 1 | 2015 | 48 | 0.510 |
Why?
|
| Chorion | 1 | 2015 | 114 | 0.510 |
Why?
|
| Urban Population | 5 | 2018 | 2025 | 0.510 |
Why?
|
| Lipoproteins | 2 | 2015 | 881 | 0.500 |
Why?
|
| Fatigue | 2 | 2014 | 1542 | 0.500 |
Why?
|
| Risk | 20 | 2017 | 9599 | 0.500 |
Why?
|
| Calcium, Dietary | 2 | 2016 | 529 | 0.500 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 2 | 2014 | 415 | 0.500 |
Why?
|
| Sleep Apnea, Obstructive | 4 | 2022 | 1852 | 0.500 |
Why?
|
| Central Nervous System Stimulants | 3 | 2013 | 1176 | 0.500 |
Why?
|
| Periodontal Diseases | 2 | 2009 | 451 | 0.490 |
Why?
|
| ARNTL Transcription Factors | 1 | 2015 | 94 | 0.490 |
Why?
|
| Organ Size | 4 | 2015 | 2252 | 0.490 |
Why?
|
| Factor Analysis, Statistical | 6 | 2018 | 999 | 0.490 |
Why?
|
| Occupational Medicine | 2 | 2012 | 114 | 0.490 |
Why?
|
| Psychotic Disorders | 3 | 2019 | 3193 | 0.490 |
Why?
|
| Mitochondria | 3 | 2018 | 3584 | 0.490 |
Why?
|
| Middle Aged | 66 | 2024 | 219568 | 0.490 |
Why?
|
| Sex Hormone-Binding Globulin | 2 | 2014 | 546 | 0.480 |
Why?
|
| Exercise | 11 | 2018 | 5788 | 0.480 |
Why?
|
| Cross-Over Studies | 6 | 2019 | 2048 | 0.470 |
Why?
|
| Amnion | 1 | 2015 | 197 | 0.470 |
Why?
|
| Psychiatric Status Rating Scales | 10 | 2017 | 6013 | 0.460 |
Why?
|
| Cesarean Section | 2 | 2018 | 1385 | 0.460 |
Why?
|
| Minority Groups | 2 | 2021 | 1206 | 0.460 |
Why?
|
| Parity | 8 | 2014 | 925 | 0.460 |
Why?
|
| International Cooperation | 1 | 2020 | 1430 | 0.460 |
Why?
|
| Pyruvates | 1 | 2014 | 84 | 0.460 |
Why?
|
| 3-Hydroxybutyric Acid | 1 | 2014 | 74 | 0.460 |
Why?
|
| Sex Factors | 21 | 2019 | 10504 | 0.460 |
Why?
|
| Polymorphism, Single Nucleotide | 11 | 2024 | 15773 | 0.460 |
Why?
|
| Fasting | 3 | 2015 | 1599 | 0.460 |
Why?
|
| Child | 36 | 2024 | 79818 | 0.460 |
Why?
|
| Pilot Projects | 12 | 2021 | 8553 | 0.450 |
Why?
|
| Migraine without Aura | 1 | 2014 | 82 | 0.450 |
Why?
|
| International Classification of Diseases | 2 | 2018 | 892 | 0.450 |
Why?
|
| Iron, Dietary | 2 | 2011 | 148 | 0.450 |
Why?
|
| Metals | 1 | 2018 | 717 | 0.440 |
Why?
|
| Allostasis | 1 | 2014 | 72 | 0.440 |
Why?
|
| Recreation | 5 | 2008 | 119 | 0.440 |
Why?
|
| Self Report | 6 | 2017 | 3714 | 0.440 |
Why?
|
| Physical Fitness | 4 | 2022 | 732 | 0.440 |
Why?
|
| Multivariate Analysis | 13 | 2016 | 12096 | 0.420 |
Why?
|
| Thinness | 3 | 2014 | 490 | 0.420 |
Why?
|
| Body Height | 4 | 2016 | 1567 | 0.420 |
Why?
|
| Gene Expression | 5 | 2015 | 7583 | 0.420 |
Why?
|
| Actigraphy | 2 | 2015 | 518 | 0.410 |
Why?
|
| Needs Assessment | 2 | 2018 | 1141 | 0.410 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2015 | 463 | 0.410 |
Why?
|
| MicroRNAs | 5 | 2018 | 3783 | 0.410 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 2 | 2006 | 691 | 0.410 |
Why?
|
| Atherosclerosis | 4 | 2017 | 3401 | 0.410 |
Why?
|
| Migraine with Aura | 1 | 2014 | 203 | 0.410 |
Why?
|
| Genetic Predisposition to Disease | 11 | 2024 | 17768 | 0.410 |
Why?
|
| Cardiovascular Diseases | 13 | 2024 | 15399 | 0.400 |
Why?
|
| Pandemics | 8 | 2024 | 8611 | 0.400 |
Why?
|
| Malus | 2 | 2022 | 50 | 0.400 |
Why?
|
| Coercion | 2 | 2009 | 69 | 0.400 |
Why?
|
| DNA Damage | 2 | 2013 | 2439 | 0.400 |
Why?
|
| Northwestern United States | 3 | 2018 | 20 | 0.400 |
Why?
|
| Epidemiology | 1 | 2014 | 279 | 0.390 |
Why?
|
| Homocysteine | 2 | 2006 | 638 | 0.390 |
Why?
|
| Unemployment | 1 | 2013 | 208 | 0.390 |
Why?
|
| Achievement | 1 | 2013 | 289 | 0.390 |
Why?
|
| Sexual Partners | 3 | 2013 | 791 | 0.390 |
Why?
|
| Interviews as Topic | 9 | 2017 | 2676 | 0.390 |
Why?
|
| Registries | 8 | 2021 | 8175 | 0.390 |
Why?
|
| Triglycerides | 10 | 2019 | 2451 | 0.390 |
Why?
|
| Postpartum Period | 3 | 2015 | 1167 | 0.390 |
Why?
|
| Age Distribution | 6 | 2018 | 2882 | 0.380 |
Why?
|
| Mental Health | 6 | 2021 | 3234 | 0.380 |
Why?
|
| Environmental Exposure | 5 | 2021 | 4412 | 0.380 |
Why?
|
| Environmental Pollutants | 2 | 2018 | 1268 | 0.380 |
Why?
|
| Waist-Hip Ratio | 2 | 2018 | 516 | 0.370 |
Why?
|
| Seasons | 4 | 2023 | 1519 | 0.370 |
Why?
|
| Electronic Health Records | 2 | 2018 | 4761 | 0.370 |
Why?
|
| Regression Analysis | 6 | 2017 | 6354 | 0.370 |
Why?
|
| Parabens | 3 | 2017 | 114 | 0.370 |
Why?
|
| Dyssomnias | 1 | 2010 | 28 | 0.370 |
Why?
|
| United States | 28 | 2024 | 72136 | 0.360 |
Why?
|
| Social Class | 1 | 2019 | 1999 | 0.360 |
Why?
|
| Adiposity | 4 | 2022 | 1858 | 0.360 |
Why?
|
| Adiponectin | 5 | 2015 | 1114 | 0.360 |
Why?
|
| Cholesterol, Dietary | 1 | 2011 | 223 | 0.360 |
Why?
|
| Anthropometry | 4 | 2019 | 1347 | 0.360 |
Why?
|
| Heme Oxygenase-1 | 1 | 2012 | 363 | 0.350 |
Why?
|
| Heme | 2 | 2011 | 313 | 0.350 |
Why?
|
| Interpersonal Relations | 4 | 2019 | 1433 | 0.350 |
Why?
|
| Risk Assessment | 20 | 2021 | 23884 | 0.350 |
Why?
|
| New Zealand | 7 | 2019 | 352 | 0.350 |
Why?
|
| Hyperglycemia | 3 | 2023 | 1368 | 0.350 |
Why?
|
| Checklist | 1 | 2017 | 827 | 0.350 |
Why?
|
| Gastroschisis | 1 | 2011 | 99 | 0.340 |
Why?
|
| Trachoma | 1 | 2009 | 18 | 0.340 |
Why?
|
| Eggs | 1 | 2011 | 183 | 0.340 |
Why?
|
| Toilet Facilities | 1 | 2009 | 27 | 0.340 |
Why?
|
| Body Composition | 4 | 2019 | 2416 | 0.330 |
Why?
|
| DNA Methylation | 4 | 2018 | 4373 | 0.330 |
Why?
|
| Self-Injurious Behavior | 1 | 2015 | 556 | 0.330 |
Why?
|
| Age Factors | 13 | 2024 | 18358 | 0.330 |
Why?
|
| Metabolome | 1 | 2016 | 982 | 0.330 |
Why?
|
| Dietary Fats | 1 | 2017 | 1991 | 0.330 |
Why?
|
| Seafood | 3 | 2018 | 390 | 0.320 |
Why?
|
| Polycystic Ovary Syndrome | 2 | 2024 | 376 | 0.320 |
Why?
|
| Lactic Acid | 1 | 2014 | 1133 | 0.320 |
Why?
|
| Harm Reduction | 1 | 2010 | 145 | 0.310 |
Why?
|
| Telomere | 1 | 2015 | 931 | 0.310 |
Why?
|
| Prenatal Exposure Delayed Effects | 6 | 2018 | 2496 | 0.310 |
Why?
|
| Eligibility Determination | 1 | 2012 | 419 | 0.310 |
Why?
|
| Vitamins | 2 | 2015 | 1632 | 0.310 |
Why?
|
| Vaccination | 1 | 2020 | 3355 | 0.310 |
Why?
|
| Coronavirus Infections | 3 | 2020 | 3076 | 0.310 |
Why?
|
| DNA Copy Number Variations | 1 | 2017 | 2012 | 0.310 |
Why?
|
| Water Supply | 1 | 2009 | 206 | 0.300 |
Why?
|
| Suicide | 2 | 2017 | 1599 | 0.300 |
Why?
|
| Perception | 1 | 2014 | 1197 | 0.300 |
Why?
|
| Pneumonia, Viral | 3 | 2020 | 3196 | 0.300 |
Why?
|
| Cystatins | 1 | 2008 | 55 | 0.300 |
Why?
|
| Time Factors | 16 | 2024 | 39872 | 0.300 |
Why?
|
| Abortion, Spontaneous | 2 | 2003 | 530 | 0.300 |
Why?
|
| Outpatients | 1 | 2016 | 1591 | 0.300 |
Why?
|
| Alcohol-Related Disorders | 1 | 2010 | 235 | 0.290 |
Why?
|
| Health Care Rationing | 2 | 2021 | 434 | 0.290 |
Why?
|
| Models, Statistical | 2 | 2020 | 5070 | 0.290 |
Why?
|
| Hospitalization | 3 | 2018 | 10652 | 0.290 |
Why?
|
| Infant, Small for Gestational Age | 4 | 2019 | 460 | 0.290 |
Why?
|
| Abortion, Induced | 2 | 2003 | 460 | 0.290 |
Why?
|
| Aggression | 2 | 2009 | 745 | 0.290 |
Why?
|
| Dibutyl Phthalate | 2 | 2017 | 29 | 0.290 |
Why?
|
| Aging | 2 | 2020 | 8650 | 0.280 |
Why?
|
| Spain | 3 | 2019 | 488 | 0.280 |
Why?
|
| Shellfish | 2 | 2018 | 37 | 0.280 |
Why?
|
| Dietary Fiber | 2 | 2008 | 759 | 0.280 |
Why?
|
| Emigrants and Immigrants | 1 | 2013 | 539 | 0.280 |
Why?
|
| Quality of Life | 7 | 2022 | 13285 | 0.280 |
Why?
|
| Pregnancy, Unplanned | 1 | 2007 | 88 | 0.280 |
Why?
|
| Health Services Needs and Demand | 1 | 2015 | 1402 | 0.280 |
Why?
|
| Leukocytes | 1 | 2015 | 2025 | 0.270 |
Why?
|
| Fetal Death | 3 | 2015 | 434 | 0.270 |
Why?
|
| Epidemiologic Studies | 4 | 2016 | 670 | 0.270 |
Why?
|
| Incidence | 12 | 2021 | 21272 | 0.270 |
Why?
|
| Reproduction | 1 | 2011 | 646 | 0.270 |
Why?
|
| Malondialdehyde | 1 | 2006 | 111 | 0.270 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 1 | 2 | 2005 | 125 | 0.260 |
Why?
|
| Fatty Acids | 1 | 2014 | 1803 | 0.260 |
Why?
|
| Metabolic Diseases | 3 | 2019 | 682 | 0.260 |
Why?
|
| Genetic Variation | 3 | 2018 | 6548 | 0.260 |
Why?
|
| Fetal Macrosomia | 3 | 2018 | 131 | 0.260 |
Why?
|
| Morbidity | 1 | 2011 | 1754 | 0.260 |
Why?
|
| World Health Organization | 3 | 2020 | 1312 | 0.250 |
Why?
|
| Language | 2 | 2018 | 1532 | 0.250 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2021 | 3175 | 0.250 |
Why?
|
| Yoga | 2 | 2020 | 281 | 0.250 |
Why?
|
| Hypothalamo-Hypophyseal System | 3 | 2023 | 699 | 0.250 |
Why?
|
| Body Burden | 2 | 2016 | 158 | 0.250 |
Why?
|
| Diabetes Mellitus, Type 2 | 7 | 2017 | 12075 | 0.250 |
Why?
|
| Genome-Wide Association Study | 7 | 2024 | 12604 | 0.250 |
Why?
|
| Self Concept | 2 | 2008 | 1041 | 0.240 |
Why?
|
| Sexual Behavior | 1 | 2015 | 2158 | 0.240 |
Why?
|
| Alcohol Drinking | 4 | 2011 | 4018 | 0.240 |
Why?
|
| Hemodynamics | 1 | 2015 | 4159 | 0.240 |
Why?
|
| Linear Models | 8 | 2015 | 5862 | 0.240 |
Why?
|
| Preventive Medicine | 1 | 2006 | 247 | 0.240 |
Why?
|
| Peer Group | 1 | 2010 | 677 | 0.240 |
Why?
|
| Wounds and Injuries | 1 | 2017 | 2476 | 0.240 |
Why?
|
| Diabetes Mellitus | 6 | 2016 | 5816 | 0.230 |
Why?
|
| Periodicity | 1 | 2005 | 348 | 0.230 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 2006 | 899 | 0.230 |
Why?
|
| Oxidative Stress | 2 | 2015 | 3099 | 0.230 |
Why?
|
| C-Peptide | 1 | 2005 | 433 | 0.230 |
Why?
|
| Hyperhomocysteinemia | 1 | 2004 | 118 | 0.220 |
Why?
|
| Psychotropic Drugs | 1 | 2009 | 883 | 0.220 |
Why?
|
| Educational Status | 4 | 2015 | 2513 | 0.220 |
Why?
|
| Hyperuricemia | 1 | 2006 | 224 | 0.220 |
Why?
|
| Population Surveillance | 4 | 2019 | 2606 | 0.220 |
Why?
|
| Lipase | 1 | 2005 | 324 | 0.220 |
Why?
|
| Medical Oncology | 1 | 2015 | 2312 | 0.210 |
Why?
|
| Causality | 3 | 2015 | 1241 | 0.210 |
Why?
|
| Cholesterol, HDL | 6 | 2006 | 1808 | 0.210 |
Why?
|
| Medical History Taking | 2 | 2018 | 772 | 0.210 |
Why?
|
| Health Status Disparities | 5 | 2020 | 1831 | 0.210 |
Why?
|
| ROC Curve | 3 | 2016 | 3563 | 0.210 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 3 | 2012 | 1651 | 0.210 |
Why?
|
| Menorrhagia | 1 | 2022 | 59 | 0.210 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2015 | 2016 | 0.210 |
Why?
|
| Databases, Factual | 5 | 2019 | 7980 | 0.200 |
Why?
|
| Longitudinal Studies | 11 | 2021 | 14490 | 0.200 |
Why?
|
| Occupational Health | 2 | 2013 | 805 | 0.200 |
Why?
|
| Asia, Southeastern | 2 | 2012 | 113 | 0.200 |
Why?
|
| Attitude of Health Personnel | 2 | 2014 | 3867 | 0.200 |
Why?
|
| Federal Government | 1 | 2024 | 267 | 0.200 |
Why?
|
| Motivation | 2 | 2020 | 1996 | 0.200 |
Why?
|
| Genetic Loci | 3 | 2024 | 2612 | 0.190 |
Why?
|
| Reproductive History | 1 | 2003 | 211 | 0.190 |
Why?
|
| Catha | 2 | 2013 | 9 | 0.190 |
Why?
|
| Primary Prevention | 2 | 2021 | 1185 | 0.190 |
Why?
|
| Severity of Illness Index | 8 | 2015 | 15785 | 0.190 |
Why?
|
| Principal Component Analysis | 2 | 2017 | 940 | 0.190 |
Why?
|
| Pregnancy, High-Risk | 3 | 2014 | 119 | 0.190 |
Why?
|
| Fetal Distress | 2 | 2018 | 39 | 0.190 |
Why?
|
| Africa South of the Sahara | 2 | 2015 | 743 | 0.180 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2005 | 1927 | 0.180 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 2 | 2015 | 352 | 0.180 |
Why?
|
| Interview, Psychological | 2 | 2015 | 809 | 0.180 |
Why?
|
| Cytokines | 3 | 2021 | 7338 | 0.180 |
Why?
|
| Alabama | 2 | 2024 | 106 | 0.180 |
Why?
|
| Mental Health Services | 1 | 2012 | 1718 | 0.180 |
Why?
|
| Uric Acid | 1 | 2006 | 803 | 0.180 |
Why?
|
| Engineering | 1 | 2020 | 56 | 0.180 |
Why?
|
| Vitamin A | 1 | 2003 | 613 | 0.180 |
Why?
|
| Carotenoids | 1 | 2003 | 620 | 0.180 |
Why?
|
| Polysomnography | 3 | 2015 | 1824 | 0.180 |
Why?
|
| Carboxyhemoglobin | 2 | 2010 | 80 | 0.170 |
Why?
|
| Erythrocytes | 2 | 2006 | 2413 | 0.170 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2017 | 10146 | 0.170 |
Why?
|
| Propylthiouracil | 1 | 2019 | 68 | 0.170 |
Why?
|
| GPI-Linked Proteins | 1 | 2021 | 468 | 0.170 |
Why?
|
| Glucose | 1 | 2012 | 4336 | 0.170 |
Why?
|
| Transforming Growth Factor beta | 2 | 2005 | 1958 | 0.170 |
Why?
|
| Ferritins | 1 | 2002 | 597 | 0.170 |
Why?
|
| Famous Persons | 1 | 2020 | 109 | 0.170 |
Why?
|
| Fishes | 2 | 2017 | 601 | 0.170 |
Why?
|
| Magnesium | 2 | 2018 | 809 | 0.170 |
Why?
|
| Hypercholesterolemia | 1 | 2006 | 1138 | 0.170 |
Why?
|
| Lectins | 1 | 2021 | 484 | 0.170 |
Why?
|
| Family Practice | 1 | 2002 | 510 | 0.170 |
Why?
|
| Vietnam | 2 | 2012 | 410 | 0.160 |
Why?
|
| Mesalamine | 2 | 2017 | 136 | 0.160 |
Why?
|
| Infant | 10 | 2019 | 36055 | 0.160 |
Why?
|
| Mathematics | 1 | 2020 | 707 | 0.160 |
Why?
|
| Focus Groups | 2 | 2015 | 1384 | 0.160 |
Why?
|
| Counseling | 3 | 2015 | 1541 | 0.160 |
Why?
|
| Healthcare Disparities | 1 | 2015 | 3364 | 0.160 |
Why?
|
| Vitamin E | 1 | 2003 | 870 | 0.160 |
Why?
|
| Emergency Medical Services | 2 | 2021 | 1915 | 0.160 |
Why?
|
| Medicaid | 1 | 2012 | 2807 | 0.160 |
Why?
|
| Dehydroepiandrosterone | 1 | 2019 | 257 | 0.160 |
Why?
|
| Population Groups | 2 | 2017 | 211 | 0.160 |
Why?
|
| History, 21st Century | 2 | 2015 | 1573 | 0.150 |
Why?
|
| Molybdenum | 1 | 2018 | 46 | 0.150 |
Why?
|
| Lactobacillus | 1 | 2019 | 204 | 0.150 |
Why?
|
| Taste | 1 | 2019 | 188 | 0.150 |
Why?
|
| Health Services Accessibility | 2 | 2015 | 5404 | 0.150 |
Why?
|
| Sperm Motility | 2 | 2016 | 265 | 0.150 |
Why?
|
| Electric Countershock | 1 | 2021 | 533 | 0.150 |
Why?
|
| Technology | 1 | 2020 | 292 | 0.150 |
Why?
|
| Polymorphism, Genetic | 2 | 2005 | 4284 | 0.150 |
Why?
|
| Leukemia | 1 | 2006 | 1519 | 0.150 |
Why?
|
| Fetus | 2 | 2020 | 1859 | 0.150 |
Why?
|
| Puerperal Disorders | 2 | 2018 | 299 | 0.150 |
Why?
|
| Georgia (Republic) | 2 | 2007 | 39 | 0.150 |
Why?
|
| Gonadal Hormones | 1 | 2017 | 30 | 0.150 |
Why?
|
| Gonadotropins, Pituitary | 1 | 2017 | 69 | 0.150 |
Why?
|
| Parathyroid Neoplasms | 1 | 2019 | 241 | 0.150 |
Why?
|
| Science | 1 | 2020 | 239 | 0.150 |
Why?
|
| China | 2 | 2014 | 2333 | 0.150 |
Why?
|
| Plasticizers | 1 | 2017 | 50 | 0.150 |
Why?
|
| Oxidation-Reduction | 2 | 2014 | 2221 | 0.150 |
Why?
|
| Health Priorities | 1 | 2020 | 375 | 0.150 |
Why?
|
| Translating | 2 | 2016 | 143 | 0.150 |
Why?
|
| Endocrine Glands | 1 | 2017 | 101 | 0.150 |
Why?
|
| Marriage | 1 | 2019 | 350 | 0.140 |
Why?
|
| Carbon Monoxide | 2 | 2011 | 540 | 0.140 |
Why?
|
| Chronobiology Disorders | 1 | 2018 | 72 | 0.140 |
Why?
|
| Solanum tuberosum | 1 | 2017 | 40 | 0.140 |
Why?
|
| Databases, Bibliographic | 1 | 2017 | 130 | 0.140 |
Why?
|
| Meditation | 1 | 2020 | 251 | 0.140 |
Why?
|
| Boston | 3 | 2014 | 9304 | 0.140 |
Why?
|
| Out-of-Hospital Cardiac Arrest | 1 | 2021 | 327 | 0.140 |
Why?
|
| Psychological Theory | 2 | 2018 | 175 | 0.140 |
Why?
|
| Zimbabwe | 3 | 2007 | 135 | 0.140 |
Why?
|
| Sweden | 3 | 2015 | 1376 | 0.140 |
Why?
|
| Air Pollutants | 3 | 2021 | 2842 | 0.140 |
Why?
|
| Heart Rate | 3 | 2017 | 4166 | 0.140 |
Why?
|
| Aged | 18 | 2021 | 168218 | 0.140 |
Why?
|
| History, 20th Century | 2 | 2015 | 2772 | 0.140 |
Why?
|
| Hazardous Substances | 1 | 2017 | 152 | 0.140 |
Why?
|
| Fertilization | 3 | 2022 | 197 | 0.140 |
Why?
|
| Walking | 3 | 2018 | 1188 | 0.130 |
Why?
|
| Multiple Endocrine Neoplasia Type 1 | 1 | 2016 | 42 | 0.130 |
Why?
|
| Cosmetics | 1 | 2017 | 102 | 0.130 |
Why?
|
| Oxidative Phosphorylation | 1 | 2018 | 495 | 0.130 |
Why?
|
| Medical Records | 3 | 2007 | 1406 | 0.130 |
Why?
|
| Siblings | 2 | 2015 | 824 | 0.130 |
Why?
|
| Air Pollution | 2 | 2021 | 2314 | 0.130 |
Why?
|
| Ascorbic Acid | 3 | 2004 | 655 | 0.130 |
Why?
|
| Feeding Behavior | 2 | 2019 | 3184 | 0.130 |
Why?
|
| Vegetables | 2 | 2019 | 1195 | 0.130 |
Why?
|
| Iceland | 1 | 2016 | 184 | 0.130 |
Why?
|
| Pituitary-Adrenal System | 2 | 2023 | 551 | 0.130 |
Why?
|
| Epicardial Mapping | 1 | 2015 | 56 | 0.130 |
Why?
|
| Food Preferences | 1 | 2019 | 399 | 0.130 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2019 | 1006 | 0.130 |
Why?
|
| Central Venous Pressure | 1 | 2015 | 79 | 0.130 |
Why?
|
| Phthalic Acids | 2 | 2017 | 477 | 0.130 |
Why?
|
| Antioxidants | 1 | 2003 | 1662 | 0.130 |
Why?
|
| Preconception Care | 2 | 2007 | 139 | 0.130 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 2015 | 151 | 0.120 |
Why?
|
| Preservatives, Pharmaceutical | 1 | 2015 | 34 | 0.120 |
Why?
|
| Social Behavior | 2 | 2019 | 1131 | 0.120 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2015 | 3801 | 0.120 |
Why?
|
| Maternal Behavior | 1 | 2017 | 307 | 0.120 |
Why?
|
| Selenium | 1 | 2018 | 416 | 0.120 |
Why?
|
| Inflammation Mediators | 1 | 2004 | 1878 | 0.120 |
Why?
|
| House Calls | 1 | 2017 | 160 | 0.120 |
Why?
|
| Statistics as Topic | 4 | 2012 | 2359 | 0.120 |
Why?
|
| Prehypertension | 1 | 2015 | 63 | 0.120 |
Why?
|
| Decidua | 1 | 2015 | 82 | 0.120 |
Why?
|
| Chickens | 1 | 2017 | 860 | 0.120 |
Why?
|
| Cerebrovascular Disorders | 2 | 2019 | 1475 | 0.120 |
Why?
|
| Supine Position | 1 | 2015 | 205 | 0.120 |
Why?
|
| Thrombectomy | 1 | 2020 | 690 | 0.120 |
Why?
|
| Disseminated Intravascular Coagulation | 1 | 2015 | 187 | 0.120 |
Why?
|
| Arsenic | 1 | 2018 | 358 | 0.120 |
Why?
|
| History, Ancient | 1 | 2015 | 211 | 0.120 |
Why?
|
| Immune System | 1 | 2020 | 796 | 0.120 |
Why?
|
| Genotype | 3 | 2016 | 12945 | 0.120 |
Why?
|
| Estriol | 1 | 2014 | 51 | 0.120 |
Why?
|
| Telemetry | 1 | 2016 | 199 | 0.120 |
Why?
|
| Carcinoid Tumor | 1 | 2016 | 228 | 0.120 |
Why?
|
| Postpartum Hemorrhage | 1 | 2018 | 265 | 0.120 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2012 | 1539 | 0.120 |
Why?
|
| Secretory Rate | 1 | 2014 | 81 | 0.120 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2019 | 611 | 0.120 |
Why?
|
| Endometriosis | 1 | 2022 | 874 | 0.120 |
Why?
|
| Cholesterol | 5 | 2006 | 2902 | 0.120 |
Why?
|
| Vagina | 1 | 2019 | 838 | 0.120 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2010 | 4567 | 0.120 |
Why?
|
| Social Environment | 2 | 2021 | 1023 | 0.120 |
Why?
|
| Molecular Epidemiology | 1 | 2016 | 469 | 0.110 |
Why?
|
| Epigenesis, Genetic | 2 | 2018 | 3754 | 0.110 |
Why?
|
| Health Services, Indigenous | 1 | 2015 | 68 | 0.110 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2020 | 1156 | 0.110 |
Why?
|
| Greece | 1 | 2014 | 336 | 0.110 |
Why?
|
| Adipogenesis | 1 | 2016 | 358 | 0.110 |
Why?
|
| Politics | 1 | 2020 | 815 | 0.110 |
Why?
|
| Zinc | 1 | 2018 | 687 | 0.110 |
Why?
|
| Chromatography, Liquid | 2 | 2014 | 986 | 0.110 |
Why?
|
| Semen | 1 | 2016 | 346 | 0.110 |
Why?
|
| Family Characteristics | 2 | 2017 | 1000 | 0.110 |
Why?
|
| Data Mining | 1 | 2018 | 551 | 0.110 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 2 | 2005 | 256 | 0.110 |
Why?
|
| Infant, Premature | 3 | 2011 | 2092 | 0.110 |
Why?
|
| Atrial Flutter | 1 | 2015 | 252 | 0.110 |
Why?
|
| Thymus Neoplasms | 1 | 2016 | 274 | 0.110 |
Why?
|
| Rehabilitation | 1 | 2014 | 129 | 0.110 |
Why?
|
| Cultural Competency | 2 | 2017 | 297 | 0.110 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2015 | 461 | 0.110 |
Why?
|
| X-Ray Microtomography | 1 | 2015 | 443 | 0.110 |
Why?
|
| Circadian Clocks | 1 | 2015 | 163 | 0.110 |
Why?
|
| Massachusetts | 2 | 2018 | 8823 | 0.110 |
Why?
|
| Metabolomics | 3 | 2019 | 1629 | 0.110 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 2014 | 268 | 0.110 |
Why?
|
| Multilevel Analysis | 1 | 2013 | 150 | 0.110 |
Why?
|
| Early Diagnosis | 1 | 2018 | 1177 | 0.110 |
Why?
|
| Delphi Technique | 1 | 2017 | 829 | 0.110 |
Why?
|
| Somatomedins | 1 | 2013 | 178 | 0.110 |
Why?
|
| Pathology, Molecular | 1 | 2016 | 328 | 0.110 |
Why?
|
| Congenital Abnormalities | 1 | 2018 | 704 | 0.110 |
Why?
|
| Patient Participation | 1 | 2002 | 1436 | 0.110 |
Why?
|
| Embryo Implantation | 1 | 2015 | 270 | 0.110 |
Why?
|
| Shock | 1 | 2015 | 314 | 0.110 |
Why?
|
| Laos | 1 | 2012 | 27 | 0.110 |
Why?
|
| Linkage Disequilibrium | 1 | 2018 | 1996 | 0.110 |
Why?
|
| Polymerase Chain Reaction | 3 | 2014 | 6068 | 0.110 |
Why?
|
| Dizziness | 1 | 2016 | 257 | 0.110 |
Why?
|
| Hospital Mortality | 2 | 2018 | 5272 | 0.110 |
Why?
|
| Infection Control | 1 | 2020 | 982 | 0.110 |
Why?
|
| Quality Control | 1 | 2015 | 825 | 0.100 |
Why?
|
| Biological Clocks | 1 | 2015 | 316 | 0.100 |
Why?
|
| Coronary Disease | 1 | 2007 | 5917 | 0.100 |
Why?
|
| Follow-Up Studies | 10 | 2019 | 39059 | 0.100 |
Why?
|
| Urban Health | 2 | 2012 | 533 | 0.100 |
Why?
|
| Retinol-Binding Proteins, Plasma | 1 | 2012 | 94 | 0.100 |
Why?
|
| Dietary Supplements | 2 | 2016 | 3387 | 0.100 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2015 | 632 | 0.100 |
Why?
|
| Cambodia | 1 | 2012 | 186 | 0.100 |
Why?
|
| Endocrine Disruptors | 1 | 2015 | 263 | 0.100 |
Why?
|
| Pyruvaldehyde | 1 | 2012 | 16 | 0.100 |
Why?
|
| Gene Expression Profiling | 4 | 2019 | 9404 | 0.100 |
Why?
|
| Menstruation Disturbances | 2 | 2024 | 143 | 0.100 |
Why?
|
| Prolactin | 1 | 2014 | 621 | 0.100 |
Why?
|
| Testis | 1 | 2015 | 794 | 0.100 |
Why?
|
| Patient-Centered Care | 1 | 2002 | 1415 | 0.100 |
Why?
|
| Sunlight | 1 | 2013 | 337 | 0.100 |
Why?
|
| Random Allocation | 1 | 2016 | 2385 | 0.100 |
Why?
|
| Vaginal Smears | 1 | 2015 | 500 | 0.100 |
Why?
|
| Television | 1 | 2014 | 409 | 0.100 |
Why?
|
| Hospitals, General | 1 | 2016 | 795 | 0.100 |
Why?
|
| Monitoring, Physiologic | 1 | 2019 | 1780 | 0.100 |
Why?
|
| Meat | 2 | 2011 | 584 | 0.100 |
Why?
|
| Industry | 1 | 2013 | 361 | 0.090 |
Why?
|
| Spermatozoa | 1 | 2015 | 631 | 0.090 |
Why?
|
| Tandem Mass Spectrometry | 2 | 2014 | 1186 | 0.090 |
Why?
|
| Hematologic Tests | 1 | 2012 | 238 | 0.090 |
Why?
|
| Headache | 2 | 2010 | 1248 | 0.090 |
Why?
|
| Phenols | 1 | 2015 | 514 | 0.090 |
Why?
|
| Alcoholic Beverages | 1 | 2012 | 264 | 0.090 |
Why?
|
| Nutritional Status | 2 | 2016 | 1607 | 0.090 |
Why?
|
| Birth Certificates | 1 | 2011 | 71 | 0.090 |
Why?
|
| Deoxyguanosine | 1 | 2011 | 92 | 0.090 |
Why?
|
| Posture | 1 | 2015 | 953 | 0.090 |
Why?
|
| Denmark | 3 | 2019 | 759 | 0.090 |
Why?
|
| Paternal Age | 1 | 2011 | 87 | 0.090 |
Why?
|
| Reference Values | 3 | 2014 | 4919 | 0.090 |
Why?
|
| Pain Measurement | 2 | 2022 | 3527 | 0.090 |
Why?
|
| Postmenopause | 1 | 2019 | 2509 | 0.090 |
Why?
|
| Child, Preschool | 8 | 2021 | 42062 | 0.090 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2017 | 1988 | 0.090 |
Why?
|
| Age of Onset | 1 | 2017 | 3298 | 0.090 |
Why?
|
| Marital Status | 2 | 2015 | 432 | 0.090 |
Why?
|
| Cardiology | 1 | 2021 | 1667 | 0.090 |
Why?
|
| Predictive Value of Tests | 7 | 2016 | 15225 | 0.090 |
Why?
|
| Heart Conduction System | 1 | 2015 | 1011 | 0.090 |
Why?
|
| Empathy | 1 | 2015 | 473 | 0.090 |
Why?
|
| Los Angeles | 2 | 2021 | 243 | 0.090 |
Why?
|
| Executive Function | 1 | 2019 | 1374 | 0.090 |
Why?
|
| Arginine | 2 | 2012 | 933 | 0.090 |
Why?
|
| Social Perception | 3 | 2009 | 432 | 0.090 |
Why?
|
| Arousal | 1 | 2016 | 1157 | 0.090 |
Why?
|
| Spasms, Infantile | 1 | 2013 | 296 | 0.090 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2019 | 1887 | 0.090 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2017 | 2269 | 0.090 |
Why?
|
| Progesterone | 1 | 2014 | 742 | 0.090 |
Why?
|
| Head | 1 | 2016 | 921 | 0.090 |
Why?
|
| Headache Disorders | 1 | 2012 | 148 | 0.090 |
Why?
|
| Environmental Monitoring | 2 | 2021 | 1445 | 0.080 |
Why?
|
| Retrospective Studies | 13 | 2020 | 80168 | 0.080 |
Why?
|
| Cultural Characteristics | 2 | 2009 | 252 | 0.080 |
Why?
|
| Hysterectomy | 1 | 2015 | 904 | 0.080 |
Why?
|
| Patient Satisfaction | 1 | 2002 | 3446 | 0.080 |
Why?
|
| Heart Atria | 1 | 2015 | 1344 | 0.080 |
Why?
|
| Gene Regulatory Networks | 1 | 2018 | 1740 | 0.080 |
Why?
|
| Chronic Disease | 3 | 2013 | 9267 | 0.080 |
Why?
|
| Proteins | 1 | 2004 | 6026 | 0.080 |
Why?
|
| Arm | 2 | 2015 | 583 | 0.080 |
Why?
|
| Serotonin Antagonists | 1 | 2009 | 144 | 0.080 |
Why?
|
| RNA | 2 | 2009 | 2716 | 0.080 |
Why?
|
| Drinking | 1 | 2010 | 199 | 0.080 |
Why?
|
| Physician-Patient Relations | 1 | 2002 | 3242 | 0.080 |
Why?
|
| Acute Disease | 1 | 2019 | 7225 | 0.080 |
Why?
|
| Fatty Acids, Unsaturated | 2 | 2016 | 540 | 0.080 |
Why?
|
| Netherlands | 3 | 2021 | 2212 | 0.080 |
Why?
|
| Bacteria | 1 | 2019 | 2197 | 0.080 |
Why?
|
| Health Policy | 1 | 2021 | 2677 | 0.080 |
Why?
|
| Blood Transfusion | 1 | 2015 | 1321 | 0.080 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2015 | 1214 | 0.080 |
Why?
|
| Particulate Matter | 3 | 2021 | 2556 | 0.080 |
Why?
|
| Chi-Square Distribution | 1 | 2014 | 3425 | 0.080 |
Why?
|
| Weight Loss | 2 | 2013 | 2671 | 0.080 |
Why?
|
| Cholesterol, LDL | 4 | 2005 | 2374 | 0.080 |
Why?
|
| Sexual Harassment | 1 | 2009 | 83 | 0.080 |
Why?
|
| Stress, Physiological | 1 | 2016 | 1398 | 0.080 |
Why?
|
| Japan | 1 | 2012 | 1366 | 0.080 |
Why?
|
| HIV Infections | 1 | 2015 | 17275 | 0.080 |
Why?
|
| Carcinoma | 1 | 2019 | 2330 | 0.070 |
Why?
|
| New York City | 2 | 2021 | 725 | 0.070 |
Why?
|
| Infertility, Female | 1 | 2013 | 759 | 0.070 |
Why?
|
| Cholesterol Ester Transfer Proteins | 1 | 2008 | 113 | 0.070 |
Why?
|
| Lysine | 1 | 2012 | 998 | 0.070 |
Why?
|
| Nitrogen Dioxide | 2 | 2021 | 512 | 0.070 |
Why?
|
| Statistics, Nonparametric | 1 | 2012 | 2850 | 0.070 |
Why?
|
| Nutrition Surveys | 1 | 2014 | 1716 | 0.070 |
Why?
|
| PPAR alpha | 1 | 2008 | 175 | 0.070 |
Why?
|
| Guidelines as Topic | 2 | 2021 | 1386 | 0.070 |
Why?
|
| Gravidity | 1 | 2006 | 50 | 0.070 |
Why?
|
| Analysis of Variance | 1 | 2015 | 6234 | 0.070 |
Why?
|
| RNA, Messenger | 4 | 2011 | 12759 | 0.070 |
Why?
|
| Managed Care Programs | 1 | 2012 | 939 | 0.070 |
Why?
|
| Cystatin C | 1 | 2008 | 270 | 0.070 |
Why?
|
| Toll-Like Receptors | 1 | 2010 | 590 | 0.070 |
Why?
|
| Demography | 1 | 2011 | 1651 | 0.070 |
Why?
|
| Jaundice, Neonatal | 1 | 2006 | 71 | 0.070 |
Why?
|
| Receptors, Adiponectin | 1 | 2006 | 81 | 0.070 |
Why?
|
| Disability Evaluation | 1 | 2013 | 1825 | 0.070 |
Why?
|
| Substance-Related Disorders | 3 | 2013 | 4402 | 0.060 |
Why?
|
| Heart Diseases | 1 | 2019 | 2782 | 0.060 |
Why?
|
| Adenolymphoma | 1 | 2005 | 10 | 0.060 |
Why?
|
| Employment | 1 | 2012 | 1112 | 0.060 |
Why?
|
| Contraceptives, Oral, Hormonal | 1 | 2007 | 190 | 0.060 |
Why?
|
| Eclampsia | 1 | 2006 | 56 | 0.060 |
Why?
|
| Poverty | 1 | 2017 | 2692 | 0.060 |
Why?
|
| Systole | 1 | 2007 | 936 | 0.060 |
Why?
|
| Microarray Analysis | 1 | 2008 | 746 | 0.060 |
Why?
|
| Sperm Count | 2 | 2016 | 228 | 0.060 |
Why?
|
| Diastole | 1 | 2007 | 781 | 0.060 |
Why?
|
| Receptors, Adrenergic, beta-3 | 1 | 2005 | 62 | 0.060 |
Why?
|
| Interleukin-8 | 1 | 2008 | 696 | 0.060 |
Why?
|
| Anemia, Iron-Deficiency | 1 | 2009 | 368 | 0.060 |
Why?
|
| Adenoma, Pleomorphic | 1 | 2005 | 75 | 0.060 |
Why?
|
| Receptors, Leptin | 1 | 2006 | 350 | 0.060 |
Why?
|
| Mass Spectrometry | 1 | 2012 | 2189 | 0.060 |
Why?
|
| Receptors, Progesterone | 2 | 2022 | 1130 | 0.060 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2008 | 577 | 0.060 |
Why?
|
| Ascorbic Acid Deficiency | 1 | 2004 | 25 | 0.060 |
Why?
|
| Qualitative Research | 1 | 2015 | 2976 | 0.060 |
Why?
|
| Receptors, Glucocorticoid | 2 | 2016 | 295 | 0.060 |
Why?
|
| Adipose Tissue | 2 | 2007 | 3299 | 0.060 |
Why?
|
| Adaptation, Psychological | 1 | 2014 | 2629 | 0.060 |
Why?
|
| Transforming Growth Factor beta1 | 2 | 2005 | 607 | 0.060 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2016 | 4485 | 0.060 |
Why?
|
| Insulin-Like Growth Factor Binding Proteins | 1 | 2004 | 206 | 0.060 |
Why?
|
| Pregnancy Proteins | 1 | 2004 | 222 | 0.060 |
Why?
|
| Program Development | 1 | 2010 | 1298 | 0.060 |
Why?
|
| Up-Regulation | 1 | 2012 | 4113 | 0.060 |
Why?
|
| Calcifediol | 2 | 2014 | 161 | 0.060 |
Why?
|
| Interleukin-11 | 1 | 2023 | 58 | 0.050 |
Why?
|
| Benzodiazepines | 1 | 2009 | 1130 | 0.050 |
Why?
|
| Osmolar Concentration | 1 | 2004 | 660 | 0.050 |
Why?
|
| Leukemia, Myeloid | 1 | 2006 | 695 | 0.050 |
Why?
|
| Neurobiology | 1 | 2024 | 137 | 0.050 |
Why?
|
| Finland | 2 | 2015 | 603 | 0.050 |
Why?
|
| Military Personnel | 1 | 2012 | 1244 | 0.050 |
Why?
|
| Risk-Taking | 1 | 2009 | 1034 | 0.050 |
Why?
|
| Liver Neoplasms | 1 | 2018 | 4313 | 0.050 |
Why?
|
| Hypertriglyceridemia | 1 | 2006 | 293 | 0.050 |
Why?
|
| Receptors, Cell Surface | 2 | 2016 | 2825 | 0.050 |
Why?
|
| Aged, 80 and over | 5 | 2020 | 58683 | 0.050 |
Why?
|
| Lipoproteins, LDL | 1 | 2005 | 640 | 0.050 |
Why?
|
| Interleukin-1beta | 1 | 2008 | 996 | 0.050 |
Why?
|
| Coffee | 1 | 2007 | 582 | 0.050 |
Why?
|
| Sex Characteristics | 1 | 2012 | 2621 | 0.050 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2015 | 4048 | 0.050 |
Why?
|
| London | 1 | 2002 | 234 | 0.050 |
Why?
|
| Australia | 2 | 2017 | 1276 | 0.050 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2006 | 560 | 0.050 |
Why?
|
| Leukocyte Count | 1 | 2006 | 1593 | 0.050 |
Why?
|
| North Carolina | 2 | 2013 | 323 | 0.050 |
Why?
|
| Sensitivity and Specificity | 5 | 2017 | 14641 | 0.050 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2004 | 584 | 0.050 |
Why?
|
| Salivary Gland Neoplasms | 1 | 2005 | 304 | 0.050 |
Why?
|
| Program Evaluation | 1 | 2010 | 2492 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2022 | 373 | 0.050 |
Why?
|
| Receptors, Estrogen | 2 | 2022 | 2210 | 0.050 |
Why?
|
| Data Collection | 2 | 2012 | 3322 | 0.050 |
Why?
|
| Potassium | 1 | 2005 | 1310 | 0.050 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2005 | 1055 | 0.050 |
Why?
|
| Seizures | 1 | 2013 | 2919 | 0.050 |
Why?
|
| Animals | 7 | 2023 | 167768 | 0.050 |
Why?
|
| Behavior | 1 | 2003 | 540 | 0.040 |
Why?
|
| Early Detection of Cancer | 1 | 2015 | 3211 | 0.040 |
Why?
|
| Professional Practice | 1 | 2002 | 313 | 0.040 |
Why?
|
| 5-Hydroxytryptophan | 1 | 2019 | 32 | 0.040 |
Why?
|
| Prognosis | 4 | 2016 | 29557 | 0.040 |
Why?
|
| Security Measures | 1 | 2020 | 82 | 0.040 |
Why?
|
| Likelihood Functions | 1 | 2003 | 987 | 0.040 |
Why?
|
| Canada | 2 | 2015 | 2111 | 0.040 |
Why?
|
| Betaine | 1 | 2019 | 89 | 0.040 |
Why?
|
| Citrulline | 1 | 2019 | 106 | 0.040 |
Why?
|
| Italy | 1 | 2021 | 839 | 0.040 |
Why?
|
| Androgens | 1 | 2007 | 1291 | 0.040 |
Why?
|
| Docosahexaenoic Acids | 1 | 2006 | 905 | 0.040 |
Why?
|
| Insulin | 3 | 2023 | 6578 | 0.040 |
Why?
|
| Lipoproteins, HDL | 1 | 2003 | 664 | 0.040 |
Why?
|
| Occupational Exposure | 1 | 2009 | 1809 | 0.040 |
Why?
|
| Specimen Handling | 1 | 2003 | 707 | 0.040 |
Why?
|
| Carnitine | 1 | 2019 | 252 | 0.040 |
Why?
|
| Exercise Therapy | 1 | 2005 | 919 | 0.040 |
Why?
|
| Obstetrics | 1 | 2005 | 667 | 0.040 |
Why?
|
| Algorithms | 1 | 2018 | 13961 | 0.040 |
Why?
|
| Phenylalanine | 1 | 2019 | 365 | 0.040 |
Why?
|
| Jet Lag Syndrome | 1 | 2018 | 25 | 0.040 |
Why?
|
| Inflammasomes | 1 | 2023 | 527 | 0.040 |
Why?
|
| Down Syndrome | 1 | 2006 | 892 | 0.040 |
Why?
|
| England | 1 | 2019 | 524 | 0.040 |
Why?
|
| Stroke | 1 | 2020 | 9694 | 0.040 |
Why?
|
| Fast Foods | 1 | 2019 | 210 | 0.040 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2006 | 1547 | 0.040 |
Why?
|
| Treatment Outcome | 4 | 2021 | 64378 | 0.030 |
Why?
|
| Atrial Fibrillation | 1 | 2015 | 5103 | 0.030 |
Why?
|
| Fertilization in Vitro | 2 | 2015 | 1292 | 0.030 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2009 | 2125 | 0.030 |
Why?
|
| 11-beta-Hydroxysteroid Dehydrogenase Type 1 | 1 | 2016 | 21 | 0.030 |
Why?
|
| Spouses | 1 | 2019 | 279 | 0.030 |
Why?
|
| Phosphoproteins | 1 | 2005 | 2433 | 0.030 |
Why?
|
| Self Efficacy | 1 | 2020 | 632 | 0.030 |
Why?
|
| Models, Psychological | 1 | 2020 | 830 | 0.030 |
Why?
|
| Atrial Function, Right | 1 | 2015 | 32 | 0.030 |
Why?
|
| 8,11,14-Eicosatrienoic Acid | 1 | 2016 | 64 | 0.030 |
Why?
|
| Fibrosis | 1 | 2023 | 2038 | 0.030 |
Why?
|
| Embolism, Amniotic Fluid | 1 | 2015 | 20 | 0.030 |
Why?
|
| Tilt-Table Test | 1 | 2016 | 79 | 0.030 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2018 | 389 | 0.030 |
Why?
|
| Trans-Activators | 1 | 2005 | 2860 | 0.030 |
Why?
|
| Insemination, Artificial, Homologous | 1 | 2015 | 17 | 0.030 |
Why?
|
| Diet Surveys | 1 | 2019 | 1161 | 0.030 |
Why?
|
| Mentors | 1 | 2020 | 660 | 0.030 |
Why?
|
| Receptors, Thyroid Hormone | 1 | 2015 | 199 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2022 | 21017 | 0.030 |
Why?
|
| 25-Hydroxyvitamin D 2 | 1 | 2014 | 40 | 0.030 |
Why?
|
| DNA, Bacterial | 1 | 2019 | 1456 | 0.030 |
Why?
|
| Proportional Hazards Models | 2 | 2021 | 12440 | 0.030 |
Why?
|
| Paternal Exposure | 1 | 2015 | 94 | 0.030 |
Why?
|
| Brain Ischemia | 1 | 2008 | 3047 | 0.030 |
Why?
|
| Atrial Function, Left | 1 | 2015 | 184 | 0.030 |
Why?
|
| Semen Analysis | 1 | 2016 | 234 | 0.030 |
Why?
|
| Receptors, Calcitriol | 1 | 2016 | 359 | 0.030 |
Why?
|
| Parents | 2 | 2009 | 3548 | 0.030 |
Why?
|
| Poisson Distribution | 1 | 2015 | 505 | 0.030 |
Why?
|
| Government | 1 | 2015 | 161 | 0.030 |
Why?
|
| Career Choice | 1 | 2020 | 752 | 0.030 |
Why?
|
| Abdominal Fat | 1 | 2016 | 221 | 0.030 |
Why?
|
| Prostaglandins | 1 | 2015 | 398 | 0.030 |
Why?
|
| Inflammation | 2 | 2023 | 10718 | 0.030 |
Why?
|
| Fruit | 1 | 2019 | 1160 | 0.030 |
Why?
|
| Norway | 1 | 2015 | 496 | 0.030 |
Why?
|
| Diet Records | 1 | 2015 | 427 | 0.030 |
Why?
|
| Antigens, CD | 1 | 2004 | 3997 | 0.030 |
Why?
|
| Urine | 1 | 2015 | 363 | 0.030 |
Why?
|
| Oxygen Consumption | 1 | 2019 | 1845 | 0.030 |
Why?
|
| Africa, Eastern | 1 | 2013 | 76 | 0.030 |
Why?
|
| Patient Positioning | 1 | 2016 | 327 | 0.030 |
Why?
|
| Subcutaneous Fat | 1 | 2016 | 393 | 0.030 |
Why?
|
| Hospitals | 1 | 2006 | 3887 | 0.030 |
Why?
|
| Blood Chemical Analysis | 1 | 2014 | 437 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2011 | 11892 | 0.030 |
Why?
|
| Pulmonary Edema | 1 | 2015 | 408 | 0.030 |
Why?
|
| Work | 1 | 2013 | 194 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 2 | 2005 | 1705 | 0.030 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2016 | 586 | 0.030 |
Why?
|
| Developed Countries | 1 | 2015 | 440 | 0.030 |
Why?
|
| Myocardial Infarction | 2 | 2015 | 11424 | 0.020 |
Why?
|
| Israel | 1 | 2014 | 721 | 0.020 |
Why?
|
| Human Genome Project | 1 | 2012 | 199 | 0.020 |
Why?
|
| Pregnancy Rate | 1 | 2015 | 649 | 0.020 |
Why?
|
| Alleles | 2 | 2016 | 6895 | 0.020 |
Why?
|
| Receptor, erbB-2 | 1 | 2022 | 2553 | 0.020 |
Why?
|
| Haplotypes | 2 | 2008 | 2764 | 0.020 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 2015 | 864 | 0.020 |
Why?
|
| Coma | 1 | 2015 | 482 | 0.020 |
Why?
|
| Phospholipids | 1 | 2015 | 784 | 0.020 |
Why?
|
| Hyperinsulinism | 1 | 2014 | 400 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2011 | 3774 | 0.020 |
Why?
|
| Delivery, Obstetric | 1 | 2018 | 932 | 0.020 |
Why?
|
| Uterus | 1 | 2015 | 651 | 0.020 |
Why?
|
| Sleep Stages | 1 | 2015 | 691 | 0.020 |
Why?
|
| Disease Outbreaks | 1 | 2020 | 1755 | 0.020 |
Why?
|
| Intra-Abdominal Fat | 1 | 2016 | 608 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2019 | 4106 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2015 | 2284 | 0.020 |
Why?
|
| Epigenomics | 1 | 2016 | 936 | 0.020 |
Why?
|
| Energy Metabolism | 2 | 2016 | 2868 | 0.020 |
Why?
|
| Arteries | 1 | 2015 | 1125 | 0.020 |
Why?
|
| Fertility | 1 | 2015 | 773 | 0.020 |
Why?
|
| Phenotype | 2 | 2021 | 16534 | 0.020 |
Why?
|
| Absorptiometry, Photon | 1 | 2016 | 1735 | 0.020 |
Why?
|
| Carbon Monoxide Poisoning | 1 | 2010 | 65 | 0.020 |
Why?
|
| Renal Insufficiency | 1 | 2015 | 809 | 0.020 |
Why?
|
| Hyperlipidemias | 1 | 2014 | 772 | 0.020 |
Why?
|
| Receptors, Androgen | 1 | 2015 | 1077 | 0.020 |
Why?
|
| Referral and Consultation | 1 | 2002 | 3586 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2019 | 4711 | 0.020 |
Why?
|
| Neoplasms, Second Primary | 1 | 2016 | 1056 | 0.020 |
Why?
|
| Action Potentials | 1 | 2015 | 1816 | 0.020 |
Why?
|
| Life Expectancy | 1 | 2015 | 1244 | 0.020 |
Why?
|
| Oxygen | 1 | 2019 | 4191 | 0.020 |
Why?
|
| Communicable Diseases | 1 | 2016 | 877 | 0.020 |
Why?
|
| Molecular Targeted Therapy | 1 | 2019 | 2796 | 0.020 |
Why?
|
| Adenocarcinoma | 1 | 2005 | 6313 | 0.020 |
Why?
|
| Anti-Infective Agents | 1 | 2015 | 981 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2016 | 2717 | 0.020 |
Why?
|
| Diabetes Complications | 1 | 2014 | 1317 | 0.020 |
Why?
|
| Neoplasms | 1 | 2016 | 22032 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2019 | 3615 | 0.020 |
Why?
|
| Respiratory Insufficiency | 1 | 2015 | 1230 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2010 | 23342 | 0.020 |
Why?
|
| Ethinyl Estradiol | 1 | 2007 | 114 | 0.020 |
Why?
|
| Decision Making | 1 | 2020 | 3915 | 0.020 |
Why?
|
| Cause of Death | 1 | 2017 | 3675 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2005 | 18119 | 0.020 |
Why?
|
| Bayes Theorem | 1 | 2014 | 2322 | 0.020 |
Why?
|
| Veterans | 1 | 2019 | 2631 | 0.020 |
Why?
|
| Testosterone | 1 | 2015 | 2471 | 0.010 |
Why?
|
| Biological Factors | 1 | 2005 | 157 | 0.010 |
Why?
|
| Salivary Glands | 1 | 2005 | 229 | 0.010 |
Why?
|
| Anticonvulsants | 1 | 2013 | 1881 | 0.010 |
Why?
|
| Cardiomyopathies | 1 | 2015 | 1944 | 0.010 |
Why?
|
| Models, Cardiovascular | 1 | 2009 | 972 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2016 | 10112 | 0.010 |
Why?
|
| Adipocytes | 1 | 2010 | 1177 | 0.010 |
Why?
|
| Health Personnel | 1 | 2017 | 3312 | 0.010 |
Why?
|
| Models, Biological | 2 | 2010 | 9460 | 0.010 |
Why?
|
| California | 1 | 2007 | 1419 | 0.010 |
Why?
|
| Mice | 2 | 2023 | 81101 | 0.010 |
Why?
|
| Tryptophan | 1 | 2005 | 479 | 0.010 |
Why?
|
| Proteomics | 1 | 2016 | 3816 | 0.010 |
Why?
|
| RNA, Neoplasm | 1 | 2005 | 749 | 0.010 |
Why?
|
| Electrocardiography | 1 | 2016 | 6363 | 0.010 |
Why?
|
| Disease Progression | 1 | 2019 | 13468 | 0.010 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2016 | 2420 | 0.010 |
Why?
|
| DNA Primers | 1 | 2005 | 2816 | 0.010 |
Why?
|
| Calcium-Binding Proteins | 1 | 2005 | 1066 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2005 | 1694 | 0.010 |
Why?
|
| Genomics | 1 | 2016 | 5790 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2011 | 5199 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2019 | 11709 | 0.010 |
Why?
|
| Electroencephalography | 1 | 2013 | 6187 | 0.010 |
Why?
|
| Heterozygote | 1 | 2005 | 2797 | 0.010 |
Why?
|
| Family Health | 1 | 2003 | 1257 | 0.010 |
Why?
|
| Gene Frequency | 1 | 2005 | 3612 | 0.010 |
Why?
|
| Risk Reduction Behavior | 1 | 2004 | 1098 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2011 | 7590 | 0.010 |
Why?
|
| Biomedical Research | 1 | 2012 | 3418 | 0.010 |
Why?
|
| Primary Health Care | 1 | 2013 | 4652 | 0.010 |
Why?
|
| Disease Susceptibility | 1 | 2003 | 1788 | 0.010 |
Why?
|
| Lipid Metabolism | 1 | 2004 | 1895 | 0.010 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2005 | 2800 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2007 | 10748 | 0.010 |
Why?
|
| DNA | 1 | 2008 | 7199 | 0.010 |
Why?
|
| Survival Rate | 1 | 2008 | 12721 | 0.010 |
Why?
|
| Dementia | 1 | 2008 | 2650 | 0.010 |
Why?
|
| Heart Failure | 1 | 2015 | 11593 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2005 | 8506 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2005 | 7843 | 0.000 |
Why?
|
| DNA-Binding Proteins | 1 | 2005 | 9574 | 0.000 |
Why?
|
| Brain | 1 | 2013 | 26947 | 0.000 |
Why?
|
| Transcription Factors | 1 | 2005 | 12094 | 0.000 |
Why?
|